Healthcare
More news about this topic
-
Medtech Public Comp SheetMedtech Public Comp Sheet: Tools Rally as Devices Stall
October 19, 2026Our Medtech Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded medtech companies.Research
Learn more -
Healthcare Services Public Comp SheetHealthcare Services Public Comp Sheet: Payers and VBC Hand Back Some of the Q2 Rebound
October 19, 2026Our Healthcare Services Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded healthcare services companies.Research
Learn more -
Private EquityThurston Group explores sale of cosmetic injection provider Alpha
October 14, 2026The 37-location med-spa chain could hit the market as soon as 2027, testing buyer appetite in a market waiting for exits.Article
Learn more -
MedtechBrain-Computer Interfaces: The Paralyzed Will Walk
October 9, 2026This analyst note examines the BCI market’s TAM expansion, Neuralink’s competitive positioning, and underappreciated investment opportunities in adjacent sectors such as surgical robotics and psychiatry.Research
Learn more -
HealthcareCrowded deals, peak valuations sink healthcare PE’s edge
October 5, 2026Specialist healthcare funds that once beat the market by 12 points now lag it, even as capital floods in.Article
Learn more -
Healthcare Funds ReportHealthcare Funds Report
October 1, 2026The H1 2026 Healthcare Funds Report offers a comprehensive guide to healthcare and life sciences specialist managers across both private equity and venture capital.Research
Learn more -
Pharma Biotools QuarterlyPharma Biotools Report: Steady Top Line as Frontier AI Labs Move In
August 28, 2026The Q2 2026 Pharma Biotools Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.Research
Learn more -
HealthcarePE healthcare rollups have a seven-year itch they can’t scratch
August 20, 2026Once-hot sectors like dentistry and veterinary services are running short on large buyers and clean rollup integrations.Article
Learn more -
Pharma Services QuarterlyPharma Services Report: Finding a Floor
August 17, 2026The Q2 2026 Pharma Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.Research
Learn more -
Analyst NoteHealthcare IT PE Update: Deal Counts on Pace to Surpass 2021 Record
August 17, 2026The H1 2026 Healthcare IT PE Update highlights recent PE deal activity and dominant trends in healthcare IT.Research
Learn more -
Healthcare Services ReportHealthcare Services Report: Gusting Macroeconomic Headwinds Impede Progress
August 14, 2026The Q2 2026 Healthcare Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.Research
Learn more -
Medtech QuarterlyMedtech Report: MiRus Lifts VC Funding in Q2
July 31, 2026The Q2 2026 Medtech Report report provides an analysis of recent VC and PE activity and includes a market map of leading VC- and PE-backed companies in the space.Research
Learn more -
Healthtech QuarterlyHealthtech Report: Commure’s $7 Billion Raise Headlines a Slow Quarter
July 27, 2026The Q2 2026 Healthtech Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.Research
Learn more -
Biopharma QuarterlyBiopharma Report: Funding Tops $10 Billion with Record Exits
July 24, 2026The Q2 2026 Biopharma Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.Research
Learn more -
Healthcare Services Public Comp SheetHealthcare Services Public Comp Sheet: Robust Q2 Rebound After Being Left for Dead
July 15, 2026Our Healthcare Services Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded healthcare services companies.Research
Learn more -
CommentaryParabilis now the largest VC-backed biotech IPO
June 10, 2026The stock jumped 58% in its first day of trading on the Nasdaq Global Select Market on Wednesday.Article
Learn more -
Pharma Biotools QuarterlyPharma Biotools VC Trends
June 3, 2026The Q1 2026 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.Research
Learn more -
Venture CapitalSome investors are turning to biotech as a hedge against potential AI bubbles
May 29, 2026They’re betting that with the continuous need for health care, the sector is more immune.Article
Learn more